Literature DB >> 25519160

Plasma microRNA-100 is associated with coronary plaque vulnerability.

Takeshi Soeki1, Koji Yamaguchi, Toshiyuki Niki, Etsuko Uematsu, Sachiko Bando, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Junko Hotchi, Takeshi Tobiume, Shusuke Yagi, Daiju Fukuda, Yoshio Taketani, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro, Masataka Sata.   

Abstract

BACKGROUND: Although numerous studies have reported altered plasma levels of various microRNAs (miRNAs) in patients with cardiovascular disease, there are no data on the relationship between plasma miRNAs and vulnerable coronary plaque. In this study, we investigated whether plasma miRNAs might be a sensitive marker of coronary plaque vulnerability. METHODS AND
RESULTS: Integrated backscatter intravascular ultrasound (IB-IVUS) was performed in 32 consecutive patients with angina pectoris who underwent percutaneous coronary intervention. Three-dimensional analysis of IB-IVUS was performed to determine the percentage of lipid volume (%LV) and fibrous volume (%FV). Circulating miRNAs were measured in EDTA-plasma simultaneously obtained from the aorta and the coronary sinus (CS). Muscle-enriched (miR-133a, miR-208a, miR-499), vascular-enriched (miR-92a, miR-100, miR-126, miR-127, miR-145), and myeloid cell-enriched miRNAs (miR-155, miR-223) were measured. Plasma miR-100 was higher in the CS than in the aorta, but there were no significant differences in the levels of other miRNAs between the aorta and CS. Plasma miR-100 in the aorta was positively correlated with %LV (r=0.48, P<0.01) and negatively correlated with %FV (r=-0.41, P<0.05). Importantly, transcoronary concentration gradient of circulating miR-100 was more strongly correlated with %LV (r=0.53, P<0.01) and %FV (r=-0.56, P<0.01).
CONCLUSIONS: miR-100 might be released into the coronary circulation from vulnerable coronary plaques. This study provides insights into the role of miRNAs in coronary atherosclerotic disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25519160     DOI: 10.1253/circj.CJ-14-0958

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

Review 1.  Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk.

Authors:  Federico Biscetti; Elisabetta Nardella; Andrea Leonardo Cecchini; Andrea Flex; Raffaele Landolfi
Journal:  Intern Emerg Med       Date:  2020-01-09       Impact factor: 3.397

2.  Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.

Authors:  Motoki Yamashita; Atsushi Iwata; Yuta Kato; Makito Futami; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Heart Vessels       Date:  2018-04-25       Impact factor: 2.037

3.  Differential Expression of MicroRNAs in Endarterectomy Specimens Taken from Patients with Asymptomatic and Symptomatic Carotid Plaques.

Authors:  Birgit Markus; Karsten Grote; Michael Worsch; Behnoush Parviz; Andreas Boening; Bernhard Schieffer; Mariana S Parahuleva
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 4.  Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation.

Authors:  Masashi Ishikawa; Masae Iwasaki; Atsuhiro Sakamoto; Daqing Ma
Journal:  BMC Anesthesiol       Date:  2021-03-09       Impact factor: 2.217

Review 5.  Oxidative Stress in Ischemic Heart Disease.

Authors:  Aleksandar Kibel; Ana Marija Lukinac; Vedran Dambic; Iva Juric; Kristina Selthofer-Relatic
Journal:  Oxid Med Cell Longev       Date:  2020-12-28       Impact factor: 6.543

6.  Circulating miRNA levels differ with respect to carotid plaque characteristics and symptom occurrence in patients with carotid artery stenosis and provide information on future cardiovascular events.

Authors:  Rafal Badacz; Tadeusz Przewłocki; Jacek Gacoń; Ewa Stępień; Francisco J Enguita; Izabela Karch; Krzysztof Żmudka; Anna Kabłak-Ziembicka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

Review 7.  Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease.

Authors:  Linsey J F Peters; Erik A L Biessen; Mathias Hohl; Christian Weber; Emiel P C van der Vorst; Donato Santovito
Journal:  Front Physiol       Date:  2020-07-07       Impact factor: 4.566

Review 8.  The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Thozhukat Sathyapalan; Khalid Al-Rasadi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Immunol Res       Date:  2020-07-25       Impact factor: 4.818

9.  Alteration in the expression of the renin-angiotensin system in the myocardium of mice conceived by in vitro fertilization.

Authors:  Qijing Wang; Yue Zhang; Fang Le; Ning Wang; Fan Zhang; Yuqin Luo; Yiyun Lou; Minhao Hu; Liya Wang; Lisa M Thurston; Xiangrong Xu; Fan Jin
Journal:  Biol Reprod       Date:  2018-12-01       Impact factor: 4.285

Review 10.  Circulating microRNA as a Biomarker for Coronary Artery Disease.

Authors:  Ibrahim T Fazmin; Zakaria Achercouk; Charlotte E Edling; Asri Said; Kamalan Jeevaratnam
Journal:  Biomolecules       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.